Sunshine Biopharma Inc. (SBFM) stock
SBFMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFMW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 10/30
$2.54−0.06 (-2.31%)
Close on Nov 17, 2026Market cap $9.85MP/E –Yield –
Sunshine Biopharma total assets
Total assets on the balance sheet at the end of each period.
Sunshine Biopharma's total assets was $33.63M at Jun 30, 2026. For fiscal 2025 it was $30.08M, down 1.6% from the year before. Over ten years it grew 46.2% a year on average. The highest annual figure on record is $30.56M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.08M | -1.6% |
| FY2024 | Dec 31, 2024 | $30.56M | +11.8% |
| FY2023 | Dec 31, 2023 | $27.35M | -6.5% |
| FY2022 | Dec 31, 2022 | $29.24M | +1227.5% |
| FY2021 | Dec 31, 2021 | $2.20M | +110.7% |
| FY2020 | Dec 31, 2020 | $1.05M | +965.3% |
| FY2019 | Dec 31, 2019 | $98.14K | -91.4% |
| FY2018 | Dec 31, 2018 | $1.15M | +345.3% |
| FY2017 | Dec 31, 2017 | $257.49K | +299.8% |
| FY2016 | Dec 31, 2016 | $64.40K | -90.4% |
| FY2015 | Dec 31, 2015 | $673.26K | +369.4% |
| FY2014 | Dec 31, 2014 | $143.42K | +359.1% |
| FY2013 | Dec 31, 2013 | $31.24K | -76.8% |
| FY2012 | Dec 31, 2012 | $134.79K | +26.6% |
| FY2011 | Dec 31, 2011 | $106.44K | -48.7% |
| FY2010 | Dec 31, 2010 | $207.62K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $33.63M | +5.2% |
| Q1 FY2026 | Mar 31, 2026 | $27.93M | -4.3% |
| Q4 FY2025 | Dec 31, 2025 | $30.08M | -1.6% |
| Q3 FY2025 | Sep 30, 2025 | $31.49M | +4.8% |
| Q2 FY2025 | Jun 30, 2025 | $31.97M | +9.1% |
| Q1 FY2025 | Mar 31, 2025 | $29.19M | -8.5% |
| Q4 FY2024 | Dec 31, 2024 | $30.56M | +11.8% |
| Q3 FY2024 | Sep 30, 2024 | $30.06M | +8.7% |
| Q2 FY2024 | Jun 30, 2024 | $29.30M | +3.1% |
| Q1 FY2024 | Mar 31, 2024 | $31.90M | +18.2% |
| Q4 FY2023 | Dec 31, 2023 | $27.35M | -6.5% |
| Q3 FY2023 | Sep 30, 2023 | $27.65M | -32.3% |
| Q2 FY2023 | Jun 30, 2023 | $28.41M | -32.3% |
| Q1 FY2023 | Mar 31, 2023 | $26.99M | +101.3% |
| Q4 FY2022 | Dec 31, 2022 | $29.24M | +1227.5% |
| Q3 FY2022 | Sep 30, 2022 | $40.86M | +1533.3% |
| Q2 FY2022 | Jun 30, 2022 | $41.99M | +2210.9% |
| Q1 FY2022 | Mar 31, 2022 | $13.41M | +621.5% |
| Q4 FY2021 | Dec 31, 2021 | $2.20M | +110.7% |
| Q3 FY2021 | Sep 30, 2021 | $2.50M | +354.5% |
| Q2 FY2021 | Jun 30, 2021 | $1.82M | +1211.8% |
| Q1 FY2021 | Mar 31, 2021 | $1.86M | +2818.1% |
| Q4 FY2020 | Dec 31, 2020 | $1.05M | +965.3% |
| Q3 FY2020 | Sep 30, 2020 | $550.52K | +276.2% |
| Q2 FY2020 | Jun 30, 2020 | $138.52K | +26.6% |
| Q1 FY2020 | Mar 31, 2020 | $63.69K | -94.9% |
| Q4 FY2019 | Dec 31, 2019 | $98.14K | -91.4% |
| Q3 FY2019 | Sep 30, 2019 | $146.34K | -86.7% |
| Q2 FY2019 | Jun 30, 2019 | $109.39K | -90.7% |
| Q1 FY2019 | Mar 31, 2019 | $1.25M | +24.4% |
| Q4 FY2018 | Dec 31, 2018 | $1.15M | +345.3% |
| Q3 FY2018 | Sep 30, 2018 | $1.10M | +331.4% |
| Q2 FY2018 | Jun 30, 2018 | $1.17M | +612.1% |
| Q1 FY2018 | Mar 31, 2018 | $1.00M | +4181.8% |
| Q4 FY2017 | Dec 31, 2017 | $257.49K | +299.8% |
| Q3 FY2017 | Sep 30, 2017 | $256.00K | -57.3% |
| Q2 FY2017 | Jun 30, 2017 | $164.34K | – |
| Q1 FY2017 | Mar 31, 2017 | $23.41K | – |
| Q4 FY2016 | Dec 31, 2016 | $64.40K | – |
| Q3 FY2016 | Sep 30, 2016 | $599.32K | – |
See a number that looks wrong?